Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Venus RemediesBOM:526953 +5.00%53 Days Inventory is 98.74 as of Mar. 2026, which is 26% below its 10-year median of 132.58. GuruFocus rates BOM:526953 with a GF Score™ of 53/100 and a GF Value™ of ₹468.91 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Venus Remedies ranks better than 76.6% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Venus Remedies's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹1,294 Mil. Venus Remedies's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹1,196 Mil.
Hence, Venus Remedies's Days Inventory for the
three
months ended in Mar. 2026 was 98.74.
The historical rank and industry rank for Venus Remedies's Days Inventory or its related term are showing as below:
BOM:526953'
s Days Inventory Range Over the Past 10 Years
Min: 105.73 Med: 132.58 Max: 280.18
Current: 105.73
During the past 13 years, Venus Remedies's highest Days Inventory was 280.18. The lowest was 105.73. And the median was 132.58.
BOM:526953's Days Inventory is ranked better than 76.6% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs BOM:526953: 105.73
Venus Remedies's Days Inventory
increased
from Mar. 2025 (88.98) to Mar. 2026 (98.74).
It might indicate that Venus Remedies's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Venus Remedies's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.92.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Venus Remedies's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.50.
Venus Remedies (BOM:526953) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Venus Remedies's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Venus Remedies's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Venus Remedies Days Inventory Related Terms
Venus Remedies Days Inventory Historical Data
* Premium members only.
The historical data trend for Venus Remedies's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526953 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Venus Remedies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Venus Remedies Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Venus Remedies's Days Inventory distribution charts can be found below:
* The bar in red indicates where Venus Remedies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Venus Remedies (BOM:526953) has a Days Inventory of 98.74 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Venus Remedies and its competitors. This is 26% below median its historical median of 132.58. Over the past decade, Venus Remedies' Days Inventory has ranged from 105.73 to 280.18. According to the industry distribution chart, Venus Remedies ranks #216 out of 923 companies in the Drug Manufacturers industry, placing it in the top 23.4%.
Is Venus Remedies' Days Inventory too high?
Venus Remedies' current Days Inventory of 98.74 is 26% below median its 10-year median of 132.58. Over the past 10 years, this metric has ranged from a low of 105.73 to a high of 280.18. The Drug Manufacturers industry median Days Inventory is 164.38. Venus Remedies' value of 98.74 is 39.9% below this industry median. Based on the distribution chart, Venus Remedies ranks #216 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Venus Remedies has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Venus Remedies' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Venus Remedies ranks #216 out of 923 companies for Days Inventory. This places Venus Remedies in the top 23% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.38. Venus Remedies' value of 98.74 is 39.9% below this benchmark. Historically, Venus Remedies' own Days Inventory has ranged from 105.73 to 280.18 over the past decade. While the company's 10-year median is 132.58 vs. the industry median of 164.38, Venus Remedies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Venus Remedies's current Days Inventory of 98.74 is 39.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Venus Remedies and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Venus Remedies's current Days Inventory is 98.74, which is 26% below median its own 10-year median of 132.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Venus Remedies stock overvalued right now?
Based on GuruFocus' analysis, Venus Remedies (BOM:526953) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹468.91, compared to a current price of ₹1,912.90 — trading 307.9% above its estimated fair value. The current Days Inventory is 98.74, which is 26% below median its 10-year median of 132.58 and 39.9% below the Drug Manufacturers industry median of 164.38. Venus Remedies' overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Venus Remedies (BOM:526953), the current Days Inventory is 98.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Venus Remedies (BOM:526953) Overvalued in 2026?
Based on GuruFocus' analysis, Venus Remedies stock appears to be overvalued.
The current stock price of ₹1,912.90 is trading 307.9% above its estimated GF Value™ of ₹468.91.
GuruFocus considers Venus Remedies to be Significantly Overvalued.
Key valuation signals for BOM:526953:
Days Inventory: 98.74 (26% below median its 10-year median of 132.58)
GF Value™: ₹468.91 vs. price of ₹1,912.90 (307.9% above fair value)
Industry Position: 39.9% below the Drug Manufacturers median (#216 of 923)
No single metric tells the full story. See the BOM:526953 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids and others.
53GF Score
Get the complete analysis for BOM:526953
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526953 has been successfully added to your 
